Is this one of the FTSE 100’s best shares to buy in 2021?

This FTSE 100 stock crashed in 2020, but it’s seen a steady recovery since September’s lows. Could it be one of the best shares for me to buy now?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Informa (LSE: INF) specialises in business and industry information services, and that’s surely always going to be in demand. The company also organises conferences, exhibitions and seminars around the world. There’s usually strong demand for those too, but not when we’re in the grip of a global pandemic.

The Informa share price crashed heavily in 2020 as a result of Covid-19. But with the shares now up 60% from their 52-week low, I’m wondering whether I should add Informa to my list of FTSE 100 best shares for 2021.

Before I think of the future, what about the past year? Thursday’s full-year results revealed the painful details of what happened in 2020. Earlier guesses suggested a drop in revenue of around 50%, but the reality wasn’t quite that bad. In the end, Informa achieved revenue of £1,661m, down 43% on the 2019 figure of £2,890m.

Some revenue support

The company reckoned its revenue was supported by its subscription-led business model. Clearly, that can only have a limited protective effect against the ravages of the virus-led 2020 stock market crash. But it does suggest there’s a solid business beneath it all that tempts me to see Informa as a share to buy now.

How did profit hold up? Well, Informa revealed a statutory operating loss of £880m, from an operating profit of £538m in 2019. That is largely down to a whole host of Covid-related one-offs. And on an adjusted basis, the company reports an operating profit of £268m, down from £933m. Any underlying profit in 2020 seems good to me for a company like this. But I think it’s important to remember that the Covid-19 damage is still real.

For me to consider a stock among the best shares to buy, I’d want to see decent cash. On that score, Informa’s 2020 operating cash flow was positive, and I like that. It was greatly reduced, from £965m a year previously, to £231m. But I’d say any cash flow is good for the year we’ve just had.

Best shares to buy?

I think I’m looking at a good company with solid long-term potential. But it’s not one I’d buy at any price, so how is its valuation looking? The Informa share price is still down around 30% since the start of the pandemic, but it’s recovered quite strongly since September. From its 52-week low, we’re looking at a gain of 60%. That looks healthy, but I wonder if it might be too much, too soon.

On today’s share price, the 2020 adjusted EPS figure of 9.9p gives us a P/E of 56. That might not be too meaningful against such a one-off bad year. And based on 2019’s EPS, we’d see that multiple come down to around 11. Should Informa get back to 2019 earnings levels soon, it might deserve a place on my best FTSE 100 shares list.

But we have no idea when the conferences and exhibitions business will get back to full strength. And I don’t see anything approaching that in 2021. I think there’s a strong possibility of weakness for another year or two, and I just don’t see enough safety margin in the current share price.

I won’t buy now, but I’ll keep watching.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »